会員登録
ログイン
【4282】EPSホールディングス
〔上場廃止〕
【上場廃止、2021年9月17日、MBO】CRO(臨床試験受託)、CSO(医薬品販売支援)。
類似企業：
【業界1位】
H.U.グループホールディングス
【業界1位】
H.U.グループホールディングス
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021.09 | 2021/08/03 | Q3予 | 75,000 | → | 0.0% | +7.4% | 5,500 | → | 0.0% | +14.6% | 5,900 | → | 0.0% | +18.0% | 3,300 | → | 0.0% | +26.9% |
| 2021.09 | 2021/05/07 | 修正予 | 75,000 | ↑ | +7.4% | +7.4% | 5,500 | ↑ | +14.6% | +14.6% | 5,900 | ↑ | +18.0% | +18.0% | 3,300 | ↑ | +26.9% | +26.9% |
| 2021.09 | 2021/02/02 | Q1予 | 69,800 | → | 0.0% | 0.0% | 4,800 | → | 0.0% | 0.0% | 5,000 | → | 0.0% | 0.0% | 2,600 | → | 0.0% | 0.0% |
| 2021.09 | 2020/11/05 | 当初予 | 69,800 | - | - | - | 4,800 | - | - | - | 5,000 | - | - | - | 2,600 | - | - | - |
| 2020.09 | 2020/11/05 | 実 | 66,689 | ↑ | +5.0% | -8.0% | 4,553 | ↑ | +51.8% | -26.2% | 4,978 | ↑ | +65.9% | -21.2% | 1,995 | ↑ | +59.6% | -43.6% |
| 2020.09 | 2020/08/04 | Q3予 | 63,500 | → | 0.0% | -12.4% | 3,000 | ↑ | +100.0% | -51.4% | 3,000 | ↑ | +76.5% | -52.5% | 1,250 | ↑ | +4.2% | -64.7% |
| 2020.09 | 2020/05/08 | Q2予 | 63,500 | ↓ | -12.4% | -12.4% | 1,500 | ↓ | -75.7% | -75.7% | 1,700 | ↓ | -73.1% | -73.1% | 1,200 | ↓ | -66.1% | -66.1% |
| 2020.09 | 2020/02/04 | Q1予 | 72,500 | → | 0.0% | 0.0% | 6,170 | → | 0.0% | 0.0% | 6,320 | → | 0.0% | 0.0% | 3,540 | → | 0.0% | 0.0% |
| 2020.09 | 2019/11/07 | 当初予 | 72,500 | - | - | - | 6,170 | - | - | - | 6,320 | - | - | - | 3,540 | - | - | - |
| 2019.09 | 2019/11/07 | 実 | 69,009 | ↑ | +1.3% | -4.2% | 6,279 | ↑ | +10.2% | -12.8% | 6,271 | ↑ | +8.1% | -14.7% | 3,633 | ↑ | +21.1% | -22.7% |
| 2019.09 | 2019/08/01 | Q3予 | 68,100 | ↓ | -5.4% | -5.4% | 5,700 | ↓ | -20.8% | -20.8% | 5,800 | ↓ | -21.1% | -21.1% | 3,000 | ↓ | -36.2% | -36.2% |
| 2019.09 | 2019/05/08 | Q2予 | 72,000 | → | 0.0% | 0.0% | 7,200 | → | 0.0% | 0.0% | 7,350 | → | 0.0% | 0.0% | 4,700 | → | 0.0% | 0.0% |
| 2019.09 | 2019/02/01 | Q1予 | 72,000 | → | 0.0% | 0.0% | 7,200 | → | 0.0% | 0.0% | 7,350 | → | 0.0% | 0.0% | 4,700 | → | 0.0% | 0.0% |
| 2019.09 | 2018/11/07 | 当初予 | 72,000 | - | - | - | 7,200 | - | - | - | 7,350 | - | - | - | 4,700 | - | - | - |
| 2018.09 | 2018/11/07 | 実 | 65,769 | ↓ | -0.3% | -0.3% | 7,193 | ↑ | +5.0% | +5.0% | 7,436 | ↑ | +6.2% | +6.2% | 4,388 | ↑ | +4.5% | +4.5% |
| 2018.09 | 2018/08/01 | Q3予 | 66,000 | → | 0.0% | 0.0% | 6,850 | → | 0.0% | 0.0% | 7,000 | → | 0.0% | 0.0% | 4,200 | → | 0.0% | 0.0% |
| 2018.09 | 2018/05/01 | Q2予 | 66,000 | → | 0.0% | 0.0% | - | - | - | - | 7,000 | → | 0.0% | 0.0% | 4,200 | → | 0.0% | 0.0% |
| 2018.09 | 2018/02/01 | Q1予 | 66,000 | → | 0.0% | 0.0% | 6,850 | → | 0.0% | 0.0% | 7,000 | → | 0.0% | 0.0% | 4,200 | → | 0.0% | 0.0% |
| 2018.09 | 2017/11/07 | 当初予 | 66,000 | - | - | - | 6,850 | - | - | - | 7,000 | - | - | - | 4,200 | - | - | - |
| 2017.09 | 2017/11/07 | 実 | 60,482 | → | 0.0% | +4.3% | 7,591 | → | 0.0% | +16.8% | 7,809 | → | 0.0% | +20.1% | 4,663 | → | 0.0% | +33.2% |
| 2017.09 | 2017/10/31 | 修正予 | 60,482 | ↑ | +4.3% | +4.3% | 7,591 | ↑ | +16.8% | +16.8% | 7,809 | ↑ | +20.1% | +20.1% | 4,663 | ↑ | +33.2% | +33.2% |
| 2017.09 | 2017/08/01 | Q3予 | 58,000 | → | 0.0% | 0.0% | 6,500 | → | 0.0% | 0.0% | 6,500 | → | 0.0% | 0.0% | 3,500 | → | 0.0% | 0.0% |
| 2017.09 | 2017/05/02 | Q2予 | 58,000 | → | 0.0% | 0.0% | 6,500 | → | 0.0% | 0.0% | 6,500 | → | 0.0% | 0.0% | 3,500 | → | 0.0% | 0.0% |
| 2017.09 | 2017/02/01 | Q1予 | 58,000 | → | 0.0% | 0.0% | 6,500 | → | 0.0% | 0.0% | 6,500 | → | 0.0% | 0.0% | 3,500 | → | 0.0% | 0.0% |
| 2017.09 | 2016/11/08 | 当初予 | 58,000 | - | - | - | 6,500 | - | - | - | 6,500 | - | - | - | 3,500 | - | - | - |
| 2016.09 | 2016/11/08 | 実 | 52,703 | ↑ | +0.4% | +10.3% | 6,224 | ↑ | +11.1% | +31.6% | 6,589 | ↑ | +9.8% | +41.7% | 3,966 | ↑ | +13.3% | +74.7% |
| 2016.09 | 2016/08/01 | Q3予 | 52,500 | → | 0.0% | +9.8% | 5,600 | ↑ | +7.2% | +18.4% | 6,000 | ↑ | +9.1% | +29.0% | 3,500 | ↑ | +16.7% | +54.2% |
| 2016.09 | 2016/05/02 | Q2予 | 52,500 | → | 0.0% | +9.8% | - | - | - | - | 5,500 | → | 0.0% | +18.3% | 3,000 | → | 0.0% | +32.2% |
| 2016.09 | 2016/04/26 | 修正予 | 52,500 | ↑ | +1.5% | +9.8% | 5,225 | ↑ | +10.5% | +10.5% | 5,500 | ↑ | +18.3% | +18.3% | 3,000 | ↑ | +32.2% | +32.2% |
| 2016.09 | 2016/02/01 | Q1予 | 51,700 | ↑ | +8.2% | +8.2% | 4,730 | → | 0.0% | 0.0% | 4,650 | → | 0.0% | 0.0% | 2,270 | → | 0.0% | 0.0% |
| 2016.09 | 2015/11/06 | 当初予 | 47,800 | - | - | - | 4,730 | - | - | - | 4,650 | - | - | - | 2,270 | - | - | - |
| 2015.09 | 2015/11/06 | 実 | 45,202 | ↑ | +2.5% | +2.5% | 5,482 | ↑ | +18.5% | +18.5% | 5,362 | ↑ | +23.9% | +23.9% | 2,163 | ↑ | +11.7% | +11.7% |
| 2015.09 | 2015/08/03 | Q3予 | 44,120 | → | 0.0% | 0.0% | 4,625 | → | 0.0% | 0.0% | 4,327 | → | 0.0% | 0.0% | 1,937 | → | 0.0% | 0.0% |
| 2015.09 | 2015/05/01 | Q2予 | 44,120 | → | 0.0% | 0.0% | 4,625 | → | 0.0% | 0.0% | 4,327 | → | 0.0% | 0.0% | 1,937 | → | 0.0% | 0.0% |
| 2015.09 | 2015/02/02 | Q1予 | 44,120 | → | 0.0% | 0.0% | 4,625 | → | 0.0% | 0.0% | 4,327 | → | 0.0% | 0.0% | 1,937 | → | 0.0% | 0.0% |
| 2015.09 | 2014/11/06 | 当初予 | 44,120 | - | - | - | 4,625 | - | - | - | 4,327 | - | - | - | 1,937 | - | - | - |
| 2014.09 | 2014/11/06 | 実 | 41,800 | - | - | - | 4,491 | - | - | - | 4,242 | - | - | - | 1,828 | - | - | - |
